Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Lake District pharmacy grapples with medicine shortages amidst growing crisis

Lake District pharmacy grapples with medicine shortages amidst growing crisis
79% of pharmacists fear for patient health according to Community Pharmacy England report

A Lake District pharmacy is grappling with significant medication supply issues, affecting its ability to provide essential drugs to customers amidst nationwide drug shortages.

According to Simon Butterworth, whose family has operated Collins & Butterworth Pharmacy in Hawkshead for nearly 40 years, voiced his concerns to the ITV stating that the staff is "having to spend time hunting for (medications), looking for it or doing our best to find ways to solve that problem" for distressed patients.


"They've got to know when they can get the medications they need," he added.

Butterworth also highlighted the financial strain pharmacies face due to the NHS's fixed tariff system.

"Certain items are actually costing more to buy than we get paid for them by the NHS. An item we were trying to get this morning was 250 per cent higher than the tariff price, which is significant and builds up over lots of items," he explained.

This situation reflects a broader crisis highlighted by a recent report from Community Pharmacy England (CPE), which found that 79 per cent of surveyed pharmacists believe "patient health is being put at risk due to medicine supply issues."

The National Pharmacy Agency (NPA) in a recent report highlighted that around ten pharmacies close each week, adding pressure on already overstretched GPs.

Moreover, Paul Rees, CEO of the NPA, condemned the commonplace nature of medicine shortages, calling it "totally unacceptable."

Pharmacists, he lamented, are left to navigate complex supply issues, often turning patients away due to stock unavailability.

CPE has warned that without intervention, these pressures could lead to even more closures.

Mubasher Ali, Chief Executive of Community Pharmacy Lancashire and South Cumbria told the ITV the urgency of addressing these funding issues:

"We need to make it more feasible for pharmacies. We've got to sort out this funding, it's absolutely crucial to us."

A Department of Health and Social Care (DHSC) spokesperson responded to these concerns, stating:

“There are around 14,000 licensed medicines and the overwhelming majority are in good supply. Supply issues can arise for a wide range of reasons and are not specific to the UK.

"Our priority is to mitigate risks posed by those issues and to help ensure that patients continue to get the treatments they need. Thankfully most issues can be managed with minimal impact to patients."

The spokesperson also emphasised the government's support for pharmacies:

“We recognise the vital role pharmacies play in our healthcare system and that’s why they are backed by £2.6 billion a year in government funding."

Despite this funding, the ongoing supply issues underscore a critical need for further action to ensure that pharmacies like Collins & Butterworth can continue to serve their communities effectively.

More For You

Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less
NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less